The Combination of the PARP Inhibitor Olaparib and the ATR Inhibitor VE-821 Selectively Targets ATM-Deficient Lung Cancer Cells

Jette, N; Radhamani, S; Arthur, G; Ye, R; Goutam, S; Boylos, A; Petersen, L; Bose, P; Bebb, G; Lees-Miller, S

JOURNAL OF THORACIC ONCOLOGY, 2019; 14 (10): S570